Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.30
Delayed Data
As of Aug 27
 +0.43 / +5.46%
Today’s Change
3.79
Today|||52-Week Range
12.55
+55.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues10.0K772.0K809.0K1.5M
 
 
 
 
 
Depreciation And Amortization10.0K14.0K12.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income0.00758.0K797.0K1.4M
 
 
 
 
General Expenses26.8M44.6M56.3M102.6M
 
 
 
 
 
Research And Development13.5M28.9M43.9M85.6M
 
 
 
 
 
Total Operating Expenses26.8M44.6M56.3M102.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.8M-43.8M-55.5M-101.1M
 
 
 
 
 
Extraordinary Credit9.5M1.1M1.2M449.0K
 
 
 
 
 
Extraordinary Charge-7.9M-9.1M-10.6M-34.0M
 
 
 
 
 
Interest Expense On Debt7.6M15.5M873.0K996.0K
 
 
 
 
 
Other Expenses0.000.00-1.0K23.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.8M-67.3M-65.8M-135.6M
 
 
 
 
 
Net Income-32.8M-67.3M-65.8M-135.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.9M11.8M32.9M59.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.9M11.8M32.9M59.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.60-$5.72-$2.00-$2.29
 
 
 
 
 
EPS Diluted-$5.60-$5.72-$2.00-$2.29